Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01818531 · ClinicalTrials.gov registry record · Phase 4

Adductor Canal Block for Medial Compartment Knee Arthroplasty

A Phase 4 study of Post Operative Analgesia and Medial Unicompartmental Knee Arthroplasty, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
Phase 4
Development phase
150
Enrollment target
1
Study location

NCT01818531: Completed Phase 4 study of Post Operative Analgesia and Medial Unicompartmental Knee Arthroplasty, sponsored by Wake Forest University Health Sciences.

NCT01818531 is a Phase 4 study of Post Operative Analgesia and Medial Unicompartmental Knee Arthroplasty that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 150 participants, above the 100-participant average among 5 other Post Operative Analgesia trials with a reported enrollment target (50% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01818531, a Phase 4 study of Post Operative Analgesia and Medial Unicompartmental Knee Arthroplasty, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
Phase 4
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the affects of a single injection ultrasound-guided adductor canal block for patients undergoing robotic-assisted (MAKOplasty) medial UKA (unicompartmental knee arthroplasty). Specifically, this study will compare the adequacy of postoperative analgesia provided by the adductor canal block with that provided by single injection lumbar plexus blockade. The working hypothesis is that the analgesia provided by the adductor canal block will be equivalent to the analgesia provided by the lumbar plexus block. The primary outcome will be a comparison of verbal numerical pain scores at rest and with movement over the first 24 hours following nerve blockade.

Primary Outcome

Comparison of verbal numerical pain scores at rest and with movement 6 hours following nerve blockade. The score range is 0-10 with higher scores denoting worse outcomes.

Interventions

  • DRUG Adductor canal block
  • DRUG Lumbar plexus block

Study Locations (1)

North Carolina

  • Wake Forest University Baptist Medical Center - Winston-Salem

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2013-04
Est. Completion 2015-05
Phase Phase 4
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT01818531 record still lists

NCT01818531 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 100-participant average among 5 other Post Operative Analgesia trials with a reported enrollment target (50% higher).

The record links to 2 conditions, with Post Operative Analgesia appearing as the primary indexed condition, and to 2 interventions - of which Adductor canal block is the first listed.

NCT01818531 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT01818531 about?

NCT01818531 is a clinical study titled "Adductor Canal Block for Medial Compartment Knee Arthroplasty". This study will evaluate the affects of a single injection ultrasound-guided adductor canal block for patients undergoing robotic-assisted (MAKOplasty) medial UKA (unicompartmental knee arthroplasty). Specifically, this study will compare the adequacy of postoperative analgesia provided by the adduc...

What is the current status of trial NCT01818531?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2013-04. Estimated completion is 2015-05.

What conditions does trial NCT01818531 study?

This clinical trial studies the following conditions: Post Operative Analgesia, Medial Unicompartmental Knee Arthroplasty.

What interventions are being tested in trial NCT01818531?

The interventions under investigation include: Adductor canal block (DRUG), Lumbar plexus block (DRUG).

Who is sponsoring clinical trial NCT01818531?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01818531 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Operative Analgesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01818531, the US trial registry maintained by the National Library of Medicine. NCT01818531 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.